Quantitation of cross-linked fibrin degradation products in human plasma
* This volume does not allow for repeat testing
Specimens must be filled to minimum fill indicator line on the tube. BD Vacutainer Plus Citrate Tube Draw Volume Guide
If collected utilizing a "butterfly" collection device (also known as a Safety-Lok Collection Set), an extra discard Blue Tube must be drawn first to remove air from the line. If this is not done, the Blue Top Tube will not be filled properly due to the vacuum in tube and a redraw will be required
Note:
Collection of blood for coagulation testing through intravenous lines that have been previously flushed with heparin should be avoided, if possible.
If the blood must be drawn through an indwelling catheter, possible heparin contamination and specimen dilution should be considered. To decrease chance of heparin contamination:
For samples collected from a normal saline lock (capped off venous port), twice the dead space volume of the catheter and extension set should be discarded.
Whole blood samples must be centrifuged in a centrifuged that has been validated for platelet poor plasma (PLT < 10,000/uL).
Clotted samples
Improperly filled tubes (under or overfilled)
Wrong anticoagulant (3.8% sodium citrate is NOT acceptable)
Patients with hematocrit (HCT) >55% (red cell volume is >1/2 tube volume)
Hemolyzed samples
Stability time exceeded
Frozen whole blood samples
Preferred.
Samples should be sent refrigerated only if the sample will not reach the testing location within 16 Hours of collection.
< 0.50 mg/L (FEU)
In excluding deep vein thrombosis (DVT) and pulmonary (PE): In a non-high clinical probability population, using a cutoff of 0.5 mg/L FEU, a normal (<0.5 mg/L FEU) result excludes deep vein thrombosis (DVT) and pulmonary (PE) effectively. (Negative predictive value is 96-100% and 97.5-100% respectively)
Quantitation of cross-linked fibrin degradation products in human plasma
Same day/1 to 2 days
01495379
85379